How to Buy Verve Therapeutics Stock
Verve Therapeutics Inc
Verve Therapeutics, Inc. , a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases.
Verve Therapeutics stock last closed at $5.84, up 1.04% from the previous day, and has decreased 55.62% in one year. It has overperformed other stocks in the Biotechnology industry by 0.26 percentage points. Verve Therapeutics stock is currently +35.66% from its 52-week low of $4.31, and -57.15% from its 52-week high of $13.63.
There are currently 88.8M VERV shares outstanding. The market value of VERV is $518.57M. In the past 24 hours, 922,800 VERV shares were traded.
How to Buy Verve Therapeutics Stock
Wondering how to invest in Verve Therapeutics stock? Here's how.
- Figure out where to buy Verve Therapeutics stock: You need to decide on an online brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you choose where to buy Verve Therapeutics stock.
- Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Fund your brokerage account: Pick your method of payment and add your details.
- Research Verve Therapeutics stock: The Verve Therapeutics ticker symbol is VERV. Is Verve Therapeutics stock a good investment? Should you buy shares of VERV? How do VERV's underlying business fundamentals look? Do top analysts think Verve Therapeutics is a good buy? Why has VERV's stock price moved recently? (Hint: Our stock analysis website can help you evaluate if VERV is a good stock to buy).
- Place your VERV purchase: Decide if you will purchase VERV shares at the current market price or use a limit order to purchase VERV shares at a particular price.
- Get updates on your VERV investment: Create a watchlist to get the latest news on your position in Verve Therapeutics stock.
Step 1: Figure out where to buy Verve Therapeutics stock
You will need an online brokerage account in order to access the NASDAQ market and buy VERV stock.
Our recommended brokerage: eToro
Based on our research, eToro is the best stock brokerage. eToro gives you:
- You can invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to world markets: From Technology to Financial Services, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've selected your brokerage, the next step is to fill out some personal information so you can invest in VERV today.
How to Open a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to start a new brokerage account.
- Send your application by clicking the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you have opened your account on the best stock app to use, you need to deposit funds:
Watch the walkthrough below to see the process of transferring money into your investment account.
Step 4: Research Verve Therapeutics stock
After you have identified the best place to buy Verve Therapeutics stock, it's crucial to research their stock before you buy, so you can understand the risk and opportunity.
Verve Therapeutics Numbers
VERV Fundamentals
WallStreetZen was built to help average investors do more accurate fundamental analysis quickly.
You can view all of the due diligence checks on VERV's stock page.
Is VERV stock undervalued?
Investors use many financial metrics, analyses, models, and charts to gauge VERV's true value.
Using relative valuations methods:
- VERV could be undervalued based on its P/B ratio of 1.05x, relative to Biotechnology industry P/B ratio of 4.62x
You can do more valuation analysis on VERV's stock here.
A look at VERV Cashflows and Balance Sheet
Passed Financial Due Diligence Checks:
- Total VERV debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than long-term liabilities on the VERV balance sheet.
- VERV has $529.06M in cash and short term investments. This is enough to cover its annual cash burn of $161.43M.
- There are more short-term assets than short-term liabilities on the VERV balance sheet.
- VERV has a low debt to equity ratio of 0.31.
- VERV has cash burn of 161428000. It has enough cash and short-term investments to cover this for at least one year.
Failed Financial Due Diligence Checks:
- VERV profit margin has gone up by 10.87 percentage points in the past year, but the company is still unprofitable.
Is VERV stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 3 Equities analysts who monitor VERV, the consensus analyst rating on VERV is a Strong Buy
Please keep in mind that analyst ratings are not recommendations, nor are they financial advice.
You can dive deeper into what analysts are forecasting on the Verve Therapeutics stock forecast page.
VERV Technicals
VERV Performance Numbers
Last year, VERV revenue was $32.33M. Over the last 2 year, VERV's revenue has gone up by 308.13% per year. This was faster than the Biotechnology industry average of 46.11%.
Learn more about VERV's earnings and revenue performance here.
Who is buying/selling VERV?
Over the last year, executives and large shareholders at VERV have bought more shares than they have sold.
Allison Dorval, Chief Financial Officer of VERV, was the latest VERV insider to sell. They sold $3,130.20 worth of VERV shares on Dec 2, 2024.
Dig into more about who owns VERV shares here.
Can I get consistent income from VERV stock?
No, Verve Therapeutics doesn't provide an income stream by paying out dividends.
What do other traders have to say about VERV?
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Place your VERV purchase
There are two main options:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are usually fine for most investors. - Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a specific price, use a limit order.
Hit the Open Trade button and eToro will execute the order.
If you want more help buying stocks on eToro, watch the helpful video below:
Step 6: Get updates on your VERV investment
Now that you own some shares in VERV, you'll want to keep up with your investment.
Put VERV on a watchlist to get notified of the latest news about your VERV stock.
VERV Feed
How to Buy Stock in Verve Therapeutics
To reiterate, here are the 6 steps to buy Verve Therapeutics stock:
- Figure out where to buy Verve Therapeutics stock
- Create a brokerage account
- Fund your brokerage account
- Research Verve Therapeutics stock
- Place your VERV purchase
- Get updates on your VERV investment
If you are looking for a place to buy stocks, eToro is our recommended option.
Get Started with eToro TodayIf you would like to keep an eye on your investment in Verve Therapeutics, add VERV to your watchlist below.
More Stock Buying Guides You Might Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.